Physical activity appears to clear away brain fog and significantly improve cognitive function in breast cancer survivors experiencing poor working memory and executive function following chemotherapy, according to researchers.
In a national study of 299 women with a mean duration of 8 years since chemotherapy for breast cancer, objective measures showed that moderate-to-vigorous physical activity (MVPA) was directly associated with significantly fewer cancer-related symptoms, such as fatigue (P < .001), say Diane K. Ehlers, from the Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, and colleagues.
My father, who ran the Comrades Marathon in 1979 and 1980, passed away on the 7th of June 2010. I was a young girl when he completed his ‘up and down’ run and was always planning that ‘one day – some day’ I would like to run the ‘Ultimate Human Race’. On the day my Dad passed away, I undertook to run the Comrades Marathon in 2011 and raise funds for CANSA.
I completed the Comrades Marathon (Up run) on the 29th of May 2011. I was adamant that I would one do ONE, but by the end of that gruelling day I know this race (journey) was in my blood. My running buddy (Chellaine) and I managed to raise R125,000 from friends and colleagues.
US Food and Drug Administration (FDA) has given marketing clearance for the Paxman Scalp Cooling System for reducing hair loss in breast cancer patients undergoing chemotherapy. The device becomes the second hair loss prevention system okayed by the FDA following the 2015 clearance of the DigniCap Cooling System.
However, the Paxman scalp cooler is the only one tested in a randomized clinical trial ― the Scalp Cooling Alopecia Prevention Trial (SCALP) ― first reported at a meeting and published earlier this year in JAMA Oncology. It was conducted at a number of major centers, including Baylor College of Medicine, the Memorial Sloan Kettering Cancer Center, the US Oncology Network, and the MD Anderson Cancer Center.
Some of the most promising advances in cancer research in recent years involve treatments known as immunotherapy. These advances are spurring billions of dollars in investment by drug companies, and are leading to hundreds of clinical trials. Here are answers to some basic questions about this complex and rapidly evolving field.